BALCAO · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · SMALL CAP
Cosciens Biopharma Inc. CSCIF
11 fiscal years on record · USD · FY2025 reported · SEC filings only
Growth
USD 7.5M
Revenue, FY2025 · full 11-year series below
Revenue $M
Net income $M
FY2025 · Revenue 7.5 · Net income -10.4
Compound annual growth
Revenue compounded at +15.5% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−138 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -142.5% · Net -138.1%
ROE
FY2025 · ROE -121.8%
Each USD of equity lost 122 cents this year.
The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | · | 0.0 | −0.0 | −0.0 | −0.0 |
| Income tax $B | 0.0 | 0.0 | −0.0 | 0.0 | −0.0 | 0.0 | −0.0 | 0.0 | −0.0 | 0.0 | 0.0 |
| Net income $B | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.1 |
| Free cash flow $B | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | · | · | 0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −3.27 | −5.93 | −1.89 | 1.86 | −1.82 | −3.11 | −0.35 | 0.24 | −1.12 | −2.41 | · |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | −121.8 | −89.5 | −15.5 | 15.1 | −47.6 | −95.2 | · | · | −979.6 | −179.4 | −232.0 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 48 reconciliationsAUDITED
Reconciled in 11 of 19 fiscal years. 44 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPerfumes, Cosmetics & Other Toilet Preparations
Listed onOTC market
Incorporated inoutside the United States — SEC code A6
Fiscal year endsDecember 31
Data on record since2015